Data availability Additional data that support the findings of this study are available from the corresponding authors upon reasonable request
SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism
In rare cases, improper technique or contamination can lead to a sterile abscess, tissue necrosis, or phlebitis (inflamed vein)
Your healthcare provider can assess your condition and provide appropriate guidance or treatment
SITUATIONS WHERE SAXENDA MAKES SENSE When Saxenda May Still Be Used Despite Zepbound's superior efficacy, Saxenda remains appropriate in several situations: Pediatric Patients (Ages 12-17) Saxenda was the first GLP-1 FDA-approved for adolescents 12 and older (December 2020)
In Phase 1 and 2a clinical trials, once-daily subcutaneous injections of RG7697 (0.252.5 mg) for 14 days in 56 patients with T2DM and 1.8 mg of RG7697 for 12 weeks in patients with T2DM who were poorly responsive to metformin reduced body weight and improved glycemic control